NCT05391581View on ClinicalTrials.gov

The Role of GIP and GLP-2 in Postprandial Splanchnic Blood Flow Distribution and Metabolism

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 13, 2022

Primary Completion Date

February 7, 2023

Study Completion Date

February 7, 2023

Conditions
Blood Flow
Interventions
OTHER

GIPR antagonist / study tool

Selective antagonist of the GIPR, GIP(3-30)NH2

OTHER

GLP-2R antagonist / study tool

Selective antagonist of the GLP-2R, GLP-2(3-33)

OTHER

Placebo

Saline

Trial Locations (1)

2200

Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

University of Copenhagen

OTHER